They have now developed a nanobody directed against an extracellular epitope of the mouse V-ATPase c subunit. "We show that treatment of 4T1-12B mouse breast cancer cells with this nanobody ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals potential growth. Read why RADX stock is a Hold.

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Immunotherapy is a type of cancer treatment that stimulates a ... help the tumor grow and shield it from treatments. "Our new nanobody tracer acts like a detective, locating and highlighting ...

The removal of a His-tag from the RAD202 nanobody, a modification which impacts ... HER2 is overexpressed in breast cancer as well as several other solid tumors, and represents a validated target ...

The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers ... which programme them to recognise and destroy tumour cells for cancer treatment or ...

Bringing EsoBiotech onboard will give AstraZeneca access to the biotech’s Engineered NanoBody Lentiviral (ENaBL ... and destroy either tumor cells for cancer treatment or potentially ...

The EsoBiotec Engineered NanoBody Lentiviral (ENaBL ... which programme them to recognise and destroy tumour cells for cancer treatment or autoreactive cells for potential use in immune-mediated ...

The EsoBiotec Engineered NanoBody Lentiviral (ENaBL ... which programme them to recognise and destroy tumour cells for cancer treatment or autoreactive cells for potential use in immune-mediated ...

The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers ... which programme them to recognise and destroy tumour cells for cancer treatment or ...